Showing 15 posts of 87 posts found.

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023
Medical Communications CNS, Neurology, Pharmanovia, Sanofi, acquisition

Pharmanovia has announced that it will expand its neurology portfolio with the acquisition of a selection of central nervous system …


Abbott to acquire Bigfoot Biomedical

September 6, 2023
Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes

Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …

Novo Nordisk acquires Embark Biotech and its lead metabolic programme

August 31, 2023
Business Services Cardiology, Novo Nordisk, Obesity, acquisition, metabolics, obesity

Novo Nordisk has officially acquired the biopharmaceutical company Embark Biotech, along with its lead asset metabolic programme. The teams will …


LEO Pharma to acquire Timber Pharmaceuticals for up to $36m

August 22, 2023
Business Services Dermatology, LEO Pharma, Timber Pharmaceuticals, acquisition

Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by LEO Pharma, with a total …


Biogen to acquire Reata Pharmaceuticals

July 31, 2023
Business Services Biogen, Neurology, Reata Pharmaceuticals, acquisition

Biogen and Reata Pharmaceuticals have announced that they have entered a definitive agreement under which Biogen will acquire Reata for …

Eli Lilly to acquire Versanis Bio for $1.9bn

July 17, 2023
Sales and Marketing Cardiology, Eli Lilly, Versanis Bio, acquisition, cardiometabolic diseases

Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …

Croda International acquires Solus Biotech

July 4, 2023
Business Services Croda International, Pharmacy, Solus Biotech, acquisition

Croda International has confirmed that it has successfully acquired Solus Biotech, following receipt of approval from the South Korean regulatory …


Eli Lilly to acquire Sigilon Therapeutics

June 30, 2023
Business Services Chronic Diseases, Eli Lilly, Sigilon, acquisition

Eli Lilly and Sigilon Therapeutics have announced a definitive agreement for Lilly’s acquisition of Sigilon, a biopharmaceutical company focusing on …

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023
Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

Eli Lilly to acquire DICE Therapeutics for immunology innovations

June 21, 2023
Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology

Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …

Oncimmune Holdings sells businesses to Freenome in £13m deal

May 22, 2023
Sales and Marketing Freenome, Oncimmune Holdings, Oncology, acquisition

UK-based life sciences and immunodiagnostics firm Oncimmune Holdings has announced that it has sold its Oncimmune Limited and Oncimmune Europe …

Sobi acquires CTI BioPharma Corporation for $1.7bn

May 10, 2023
Medical Communications CTI, acquisition, sobi

Swedish Orphan Biovitrum, aka Sobi, has announced that it had entered into a ‘plan of merger’ with CTI BioPharma Corp …

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …


Novartis acquires Cadent Therapeutics in potential $770 million deal

December 17, 2020
Sales and Marketing Cadent, Novartis, acquisition

Novartis has sealed an agreement with Cadent Therapeutics to acquire the firm in a deal worth up to $770 million, …


Eli Lilly scoops up gene therapy specialist Prevail Therapeutics for a potential $1.04bn

December 16, 2020
Research and Development, Sales and Marketing Eli Lilly, Prevail, acquisition

Eli Lilly has struck a deal to acquire Prevail Therapeutics in a transaction that could be valued at up to …

Latest content